Ribociclib-Induced Erythema Dyschromicum Perstans (Ashy Dermatosis)–Like Pigmentation in a Metastatic Breast Cancer Patient

Ribociclib is a selective cyclin-dependent kinase (CDK) 4/6 inhibitor that has been approved in combination with endocrine therapy for the treatment of hormone receptor-positive/human epidermal growth factor 2-negative advanced or metastatic breast cancer. The main dermatological adverse events asso...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Breast Cancer
Main Authors: Mariano, Maria, Donati, Pietro, Cameli, Norma, Pigliacelli, Flavia, Morrone, Aldo, Cristaudo, Antonio
Format: Artigo
Sprog:Inglês
Udgivet: Korean Breast Cancer Society 2020
Fag:
Case Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7920864/
https://ncbi.nlm.nih.gov/pubmed/33634626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2021.24.e1
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker